 |
|
ICDs effective in helping to prevent sudden cardiac death in patients with certain heart disorder
July 25, 2007High-risk patients with hypertrophic cardiomyopathy appear to have reduced risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders, according to a study in the July 25 issue of JAMA.
Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained athletes. HCM is a genetic disease in which the heart muscle thickens abnormally, which can interfere with the heart's electrical system, increasing the risk for life-threatening abnormal heartbeats (arrhythmias). Only in the last few years has the implantable cardioverter-defibrillator (ICD) been systematically used as a potentially life-saving treatment in high-risk patients with HCM, according to background information in the article. An ICD is a device designed to quickly detect a life-threatening, abnormal heart rhythm, and attempt to convert the rhythm back to normal by delivering an electrical shock to the heart. The effectiveness and appropriate selection of HCM patients for this therapy is not certain.
Barry J. Maron, M.D., of the Minneapolis Heart Institute Foundation, Minneapolis, and colleagues examined the clinical risk profile and incidence and effectiveness of ICD intervention in patients with HCM. The researchers analyzed data from a multicenter registry of ICDs implanted between 1986 and 2003 in 506 patients with HCM, average age 42 years. Patients were judged to be at high risk for sudden death. Average follow-up was 3.7 years.
Risk factors analyzed included history of premature HCM-related sudden death in 1 or more first-degree or other relatives younger than 50 years; massive left ventricular hypertrophy (enlargement); a certain type of nonsustained ventricular tachycardia (abnormally rapid heart rhythm); and prior unexplained syncope (temporary loss of consciousness).
Of the 506 patients, 20 percent experienced 1 or more appropriate device interventions, in which the ICD terminated ventricular fibrillation (severely abnormal heart rhythm that results in cardiac arrest) or ventricular tachycardia. Intervention rates were 10.6 percent per year for secondary prevention after cardiac arrest (5-year cumulative probability, 39 percent), and 3.6 percent per year for primary prevention (5-year probability, 17 percent).
Time to first appropriate discharge was up to 10 years, with a 27 percent probability 5 years or more after implantation. For primary prevention, 35 percent of the patients with appropriate ICD interventions had undergone implantation for only a single risk factor; likelihood of appropriate discharge was similar in patients with 1, 2, or 3 or more risk markers.
"The results of this international, multicenter study show the effectiveness and reliability of the ICD in prevention of sudden cardiac death in high-risk patients with HCM," the authors write. "An important proportion of these device interventions occurred in patients who had undergone prophylactic ICD implantation for a single risk factor. Therefore, a single marker of high-risk status may justify consideration for a primary prevention defibrillator in selected patients with HCM."
JAMA and Archives Journals
Risk factors analyzed included history of premature HCM-related sudden death in 1 or more first-degree or other relatives younger than 50 years; massive left ventricular hypertrophy (enlargement); a certain type of nonsustained ventricular tachycardia (abnormally rapid heart rhythm); and prior unexplained syncope (temporary loss of consciousness).
Of the 506 patients, 20 percent experienced 1 or more appropriate device interventions, in which the ICD terminated ventricular fibrillation (severely abnormal heart rhythm that results in cardiac arrest) or ventricular tachycardia. Intervention rates were 10.6 percent per year for secondary prevention after cardiac arrest (5-year cumulative probability, 39 percent), and 3.6 percent per year for primary prevention (5-year probability, 17 percent).
Time to first appropriate discharge was up to 10 years, with a 27 percent probability 5 years or more after implantation. For primary prevention, 35 percent of the patients with appropriate ICD interventions had undergone implantation for only a single risk factor; likelihood of appropriate discharge was similar in patients with 1, 2, or 3 or more risk markers.
"The results of this international, multicenter study show the effectiveness and reliability of the ICD in prevention of sudden cardiac death in high-risk patients with HCM," the authors write. "An important proportion of these device interventions occurred in patients who had undergone prophylactic ICD implantation for a single risk factor. Therefore, a single marker of high-risk status may justify consideration for a primary prevention defibrillator in selected patients with HCM."
JAMA and Archives Journals
Cardiac Death Current Events and Cardiac Death News RSSVulnerable plaque may be easier to detect through new imaging technology
Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Blood Pressure Drug Combination Reduces Heart Attack Deaths
Thousands of patients with high blood pressure could benefit from changing their drug treatment regimen to reduce their risk of cardiac death.
Sports-related sudden cardiac death is reduced by pre-participation cardiovascular screening
Young competitive athletes are perceived by the general population to be the healthiest members of society. The possibility that highly trained athletes may have a potentially serious cardiac condition that can predispose to life-threatening tachyarrhythmias or sudden cardiac death seems paradoxical.
Genetic testing?
Frequently, autopsy becomes the principal diagnostic tool when macro and microscopic analyses provide a conclusive diagnosis in cardiomyopathies.
Organ donation after cardiac death
The babies were dying - without life support, they might live just another few minutes. Their families had said goodbye, and wanted their newborns to become organ donors, in hopes of saving another tiny life. But the babies' conditions couldn't meet the normal standards for organ donor eligibility. What to do?
New system devised to guide doctors treating patients with symptomatic myocardial bridging
What type of intervention, if any, should cardiologists offer their patients who have a heart abnormality called myocardial bridging and symptoms of heart problems?
Children with ADHD should get heart tests before treatment with stimulant drugs
Children with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before treatment with stimulant drugs, a new American Heart Association statement recommends.
Genetic variants of USF1 are associated with the increased risk for cardiovascular disease
Cardiovascular diseases (CVD) are major contributors to morbidity and mortality worldwide. Several interacting environmental, biochemical, and genetic risk factors can increase disease susceptibility.
Malfunctioning kidneys may raise risk of sudden death in women
Women whose kidneys are poor at filtering impurities from the blood are at heightened risk of sudden cardiac death, according to a report published in Hypertension: Journal of the American Heart Association.
Angina drug potentially useful against heart rhythm disorders
A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented to today at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.
More Cardiac Death Current Events and Cardiac Death News Articles
 | Pathology of Sudden Cardiac Death: An Illustrated Guide by Brooks S., MD Edwards, Jesse E., MD Edwards Pathology of Sudden Cardiac Death provides a comprehensive review of cardiovascular disorders. While sudden cardiac death could primarily be seen as an arrhythmogenic event, this actually represents the minority of cases. For the vast majority, there is an underlying anatomic disorder of the cardiovascular system responsible for the ultimate hemodynamic collapse known as sudden cardiac death.... |
 | Fighting Sudden Cardiac Death: A Worldwide Challenge This book analyzes sudden cardiac death from the multiple perspectives of world-renowned experts.Fighting Sudden Cardiac Death: A Worldwide Challenge reviews the background of sudden cardiac death (SCD) in light of new advances in genetics, mechanisms of therapy, and prevention, thus providing the reader with a more unified view of SCD, a better understanding of the pathological mechanisms of... |
| The Cardiac Conduction System in Unexplained Sudden Death by Saroja Bharati, Maurice Lev Pathologists are often confronted with cases of sudden cardiac death. The role of anatomical abnormalities or pathological lesions of the cardiac conduction system in sudden unexplained death has previously received insufficient attention. This is due, to a large extent, to the elusive, often inocuous nature of such lesions, the ostensibly normal life previously pursued by the patients, and the... | |
 | Ventricular Arrhythmias and Sudden Cardiac Death A comprehensive text on the diagnosis and treatment of ventricular arrhythmias and sudden cardiac death * Covers the most recent developments in this exploding field, including basic mechanics; clinical syndromes and etiologies; epidemiology and risk stratification; pharmacologic therapy; ablation and surgery and implantable defibrillators * Serves as a guide to this area of... |
 | A Second Chance: Surviving Sudden Cardiac Death by Patrick Emmett A Second Chance: Surviving Sudden Cardiac Death exposes the need for a more heart-health aware society through one man's remarkable near-death experience. It was a cold January morning in the skies over Minnesota when, suddenly, in an airplane at 30,000 feet, Patrick Emmett felt a discomfort in his chest, then a numbness in his hands and pain in his right shoulder. The flight attendant asked if... |
| Myocardial infarction and cardiac death (Medicinal chemistry) | |
| The Sudden Infant Death Syndrome: Cardiac and Respiratory Mechanisms and Interventions (Annals of the New York Academy of Sciences) by Peter J. Schwartz, David P. Southall | |
| Cough CPR may work to prevent sudden cardiac death.(Across Specialties): An article from: Clinical Psychiatry News by Bruce Jancin This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on January 1, 2004. The length of the article is 627 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
| Electrophysiological Mechanisms Underlying Sudden Cardiac Death | |
| Sudden Cardiac Death: Strategies For the 1990's |
| © 2008 BrightSurf.com |